MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

Kodu・Aktsiate loetelu・Talphera Inc.

Talphera Inc.

Avatud

0.78 2.63

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.71

Max

0.79

Põhinäitajad
By Trading Economics
Sissetulek	664K -3.8M
Kasumimarginaal	-443,600
Töötajad	12

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+327.63% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	13. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-615K 33M
Eelmine avamishind	-1.85
Eelmine sulgemishind	0.78

Talphera Inc. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. apr 2026, 23:44 UTC

Market Talk

Uudisväärsed sündmused

Nikkei Likely to Fall After U.S.-Iran Peace Talks Break Down -- Market Talk

12. apr 2026, 23:38 UTC

Market Talk

Uudisväärsed sündmused

Oil Climbs as U.S.-Iran Peace Talks Fail, U.S. Navy Starts Blockade of Strait of Hormuz -- Market Talk

12. apr 2026, 23:38 UTC

Market Talk

Australia's Upstream Energy Companies Poised for Consensus Earnings Upgrades -- Market Talk

12. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Gold Falls as Dollar Strengthens After U.S.-Iran Peace Talks Collapse -- Market Talk

12. apr 2026, 23:31 UTC

Market Talk

A2 Milk's Supply Issues Likely Temporary -- Market Talk

12. apr 2026, 23:09 UTC

Market Talk

Uudisväärsed sündmused

Australian Dollar Hammered by Blockade of Iran Ports -- Market Talk

12. apr 2026, 23:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. apr 2026, 23:06 UTC

Market Talk

Australian Dollar Ripe for a Downward Correction -- Market Talk

12. apr 2026, 22:56 UTC

Uudisväärsed sündmused

Spot Gold Falls 1.9% to $4,658.65 per Ounce

12. apr 2026, 22:54 UTC

Uudisväärsed sündmused

Front-Month Brent Crude Oil Futures Rise 7.6% to $102.42 per Barrel

12. apr 2026, 22:53 UTC

Uudisväärsed sündmused

Front-Month WTI Crude Oil Futures Rise 8.3% to $104.56 per Barrel, ICE Data Show

12. apr 2026, 22:51 UTC

Uudisväärsed sündmused

Front-Month Crude Oil Futures Climb After U.S.-Iran Peace Talks Break Down

12. apr 2026, 22:50 UTC

Market Talk

Uudisväärsed sündmused

US Dollar Climbs Amid Broad Risk Off Mood In FX Market -- Market Talk

12. apr 2026, 22:37 UTC

Market Talk

Uudisväärsed sündmused

Australian Dollar Under Fire as Middle East Tensions Ratchet Up Again -- Market Talk

11. apr 2026, 08:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

11. apr 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

11. apr 2026, 08:20 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

11. apr 2026, 00:00 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Big Yachts, Big Bucks -- Barrons.com

10. apr 2026, 21:55 UTC

Omandamised, ülevõtmised, äriostud

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10. apr 2026, 21:01 UTC

Tulu

Cango Inc.: Files Annual Report on Form 20-F With SEC

10. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. apr 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

10. apr 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. apr 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10. apr 2026, 20:10 UTC

Omandamised, ülevõtmised, äriostud

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10. apr 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10. apr 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10. apr 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. apr 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10. apr 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Talphera Inc. Prognoos

Hinnasiht

By TipRanks

327.63% tõus

12 kuu keskmine prognoos

Keskmine 3.25 USD 327.63%

Kõrge 3.5 USD

Madal 3 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Talphera Inc. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Talphera Inc. aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Maksueelne kasum

Müük

Intressikulud võla pealt

Ärikasum

Ettevõttest Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.